Variant report

Variant	esv1830382
Chromosome Location	chr9:6658080-6670448
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:6667709-6667966	K562	blood:	n/a	n/a
2	ARID3A	chr9:6667619-6667991	HepG2	liver:	n/a	n/a
3	ARID3A	chr9:6664541-6665413	HepG2	liver:	n/a	n/a
4	ATF3	chr9:6664488-6664934	A549	lung:	n/a	n/a
5	ATF3	chr9:6664294-6664873	A549	lung:	n/a	n/a
6	BACH1	chr9:6667638-6667964	H1-hESC	embryonic stem cell:	n/a	n/a
7	BCL3	chr9:6664480-6665034	A549	lung:	n/a	n/a
8	BCL3	chr9:6664426-6665297	A549	lung:	n/a	chr9:6665033-6665042
9	BCLAF1	chr9:6667616-6668061	GM12878	blood:	n/a	n/a
10	BHLHE40	chr9:6664329-6665171	HepG2	liver:	n/a	n/a
11	BRCA1	chr9:6664596-6664874	Hela-S3	cervix:	n/a	n/a
12	BRCA1	chr9:6664464-6664732	HepG2	liver:	n/a	n/a
13	CEBPB	chr9:6664574-6665059	Hela-S3	cervix:	n/a	n/a
14	CEBPB	chr9:6658721-6659242	A549	lung:	n/a	chr9:6658871-6658882
15	CEBPB	chr9:6664587-6665287	HepG2	liver:	n/a	n/a
16	CEBPB	chr9:6658728-6659036	K562	blood:	n/a	chr9:6658871-6658882
17	CEBPB	chr9:6664492-6665376	HepG2	liver:	n/a	n/a
18	CEBPB	chr9:6664576-6665291	HepG2	liver:	n/a	n/a
19	CEBPB	chr9:6664453-6665284	A549	lung:	n/a	n/a
20	CEBPB	chr9:6664533-6665234	MCF-7	breast:	n/a	n/a
21	CEBPB	chr9:6658722-6659320	MCF-7	breast:	n/a	chr9:6658871-6658882
22	CEBPB	chr9:6658749-6659061	IMR90	lung:	n/a	chr9:6658871-6658882
23	CEBPB	chr9:6662560-6662584	K562	blood:	n/a	n/a
24	CEBPB	chr9:6664643-6664861	HepG2	liver:	n/a	n/a
25	CEBPB	chr9:6664551-6665250	A549	lung:	n/a	n/a
26	CEBPB	chr9:6664589-6665192	A549	lung:	n/a	n/a
27	CEBPB	chr9:6662460-6662719	HepG2	liver:	n/a	chr9:6662551-6662562
28	CEBPB	chr9:6664583-6664967	MCF-7	breast:	n/a	n/a
29	CEBPB	chr9:6658601-6659127	A549	lung:	n/a	chr9:6658871-6658882
30	CEBPB	chr9:6664875-6665208	HepG2	liver:	n/a	n/a
31	CEBPB	chr9:6658750-6659166	HepG2	liver:	n/a	chr9:6658871-6658882
32	CEBPD	chr9:6664550-6665175	HepG2	liver:	n/a	n/a
33	CEBPD	chr9:6664675-6665149	HepG2	liver:	n/a	n/a
34	CEBPZ	chr9:6664872-6665103	HepG2	liver:	n/a	n/a
35	CHD2	chr9:6664515-6664915	Hela-S3	cervix:	n/a	n/a
36	CHD2	chr9:6664463-6664849	HepG2	liver:	n/a	n/a
37	CREB1	chr9:6664175-6665459	HepG2	liver:	n/a	n/a
38	CREB1	chr9:6664317-6665332	HepG2	liver:	n/a	n/a
39	CREB1	chr9:6664582-6664891	A549	lung:	n/a	n/a
40	CREB1	chr9:6664431-6664819	A549	lung:	n/a	n/a
41	CTCF	chr9:6667800-6667950	AG04450	lung:	n/a	chr9:6667851-6667869 chr9:6667846-6667867
42	CTCF	chr9:6667780-6667930	GM12875	blood:	n/a	chr9:6667851-6667869 chr9:6667846-6667867
43	CTCF	chr9:6667820-6667970	MCF-7	breast:	n/a	chr9:6667851-6667869 chr9:6667846-6667867
44	CTCF	chr9:6667860-6668010	Hela-S3	cervix:	n/a	n/a
45	CTCF	chr9:6667750-6667974	Hela-S3	cervix:	n/a	chr9:6667851-6667869 chr9:6667846-6667867
46	CTCF	chr9:6667800-6667950	GM12867	blood:	n/a	chr9:6667851-6667869 chr9:6667846-6667867
47	CTCF	chr9:6667729-6667959	MCF-7	breast:	n/a	chr9:6667851-6667869 chr9:6667846-6667867
48	CTCF	chr9:6667760-6667910	GM12873	blood:	n/a	chr9:6667851-6667869 chr9:6667846-6667867
49	CTCF	chr9:6667760-6667910	HPF	lung:	n/a	chr9:6667851-6667869 chr9:6667846-6667867
50	CTCF	chr9:6667800-6667950	HRPEpiC	eye:	n/a	chr9:6667851-6667869 chr9:6667846-6667867

No.	Distal block	Cell Line	Cell type
1	chr9:6662765..6664429-chr9:6666367..6668579,2	MCF-7	breast:
2	chr9:6585232..6587306-chr9:6664888..6666750,2	MCF-7	breast:
3	chr9:6656639..6659482-chr9:6662780..6664665,3	MCF-7	breast:
4	chr9:6644301..6646741-chr9:6667847..6669482,2	MCF-7	breast:
5	chr9:6665749..6668244-chr9:6673822..6675444,2	MCF-7	breast:
6	chr9:6354241..6354767-chr9:6667295..6668097,2	K562	blood:
7	chr9:6667615..6669315-chr9:6679006..6681464,2	K562	blood:
8	chr9:6663029..6667664-chr9:6679639..6683357,9	MCF-7	breast:
9	chr9:6662765..6664429-chr9:6666367..6668579,2	MCF-7	breast:
10	chr9:6523722..6524445-chr9:6667595..6668159,2	K562	blood:
11	chr9:6654607..6656764-chr9:6663214..6664911,2	K562	blood:
12	chr9:6663663..6666675-chr9:6715678..6718421,3	MCF-7	breast:
13	chr9:6656639..6659482-chr9:6662780..6664665,3	MCF-7	breast:
14	chr9:6584834..6585802-chr9:6667386..6668426,5	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KDM4C-13	chr9:6662424-6662810	NONHSAT130148
2	lnc-KDM4C-13	chr9:6663156-6663366	NONHSAT130148
3	lnc-KDM4C-5	chr9:6669544-6669728	NONHSAT130145
4	lnc-KDM4C-14	chr9:6661783-6661845	NONHSAT130146
5	lnc-KDM4C-13	chr9:6663657-6663792	NONHSAT130148
6	lnc-KDM4C-5	chr9:6669544-6669728	ENSG00000236924.1
7	lnc-KDM4C-5	chr9:6670425-6670690	NONHSAT130145
8	lnc-KDM4C-14	chr9:6661291-6661345	NONHSAT130146
9	lnc-KDM4C-14	chr9:6661651-6661936	NONHSAT130147
10	lnc-KDM4C-5	chr9:6670425-6670635	ENSG00000236924.1
11	lnc-KDM4C-14	chr9:6660407-6661044	NONHSAT130146

Variant related genes	Relation type
RNF2P1	TF binding region
RN7SL123P	TF binding region
ENSG00000232946	TF binding region
ENSG00000229057	TF binding region
ENSG00000225489	chromatin interactions
ENSG00000236924	chromatin interactions
ENSG00000232946	chromatin interactions
ENSG00000178445	chromatin interactions

Extended variants
information (count: 707 )
Associated
traits (count: 107 )

Variant overlapped rSNPs/rCNVs (count:707 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7868175	chr9:6658080-6658081	Weak transcription Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs117683340	chr9:6658135-6658136	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
3	rs552944673	chr9:6658169-6658170	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
4	rs181234499	chr9:6658206-6658207	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
5	rs145574746	chr9:6658229-6658230	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
6	rs557124346	chr9:6658244-6658245	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
7	rs575398129	chr9:6658247-6658248	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
8	rs533953298	chr9:6658277-6658278	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
9	rs561465299	chr9:6658291-6658292	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
10	rs535716986	chr9:6658298-6658299	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
11	rs373441944	chr9:6658301-6658302	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs138806340	chr9:6658410-6658411	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
13	rs540527240	chr9:6658429-6658430	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
14	rs565295081	chr9:6658442-6658443	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs115533940	chr9:6658445-6658446	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs555625108	chr9:6658446-6658447	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs569043472	chr9:6658452-6658453	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs572333476	chr9:6658457-6658458	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs548810899	chr9:6658478-6658479	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs33974832	chr9:6658515-6658516	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs114477665	chr9:6658551-6658552	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs534934526	chr9:6658559-6658560	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs552964289	chr9:6658573-6658574	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
24	rs12555414	chr9:6658579-6658580	Weak transcription Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs116821020	chr9:6658611-6658612	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs12551883	chr9:6658630-6658631	Weak transcription Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs375777827	chr9:6658658-6658659	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
28	rs12551886	chr9:6658680-6658681	Weak transcription Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs56187037	chr9:6658720-6658721	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs542696220	chr9:6658729-6658730	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs185058825	chr9:6658740-6658741	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs573320776	chr9:6658761-6658762	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs75872693	chr9:6658762-6658763	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs189083890	chr9:6658763-6658764	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs398068417	chr9:6658773-6658774	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs565467092	chr9:6658791-6658792	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs577449913	chr9:6658793-6658794	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
38	rs145678900	chr9:6658807-6658808	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs562538482	chr9:6658823-6658824	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs530145423	chr9:6658851-6658852	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs10115836	chr9:6658870-6658871	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs181027552	chr9:6658879-6658880	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs528303503	chr9:6658899-6658900	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
44	rs12552845	chr9:6658900-6658901	Weak transcription Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs185135133	chr9:6658909-6658910	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs538923920	chr9:6658911-6658912	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
47	rs550600735	chr9:6658944-6658945	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
48	rs115553677	chr9:6658945-6658946	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
49	rs138236792	chr9:6658962-6658963	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
50	rs149592260	chr9:6658971-6658972	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:107)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Disorders of sex development	21048976	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Developmental delay	21147756	CNVD
Lung cancer	18438408	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Myelofibrosis	22110671	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Hepatocellular carcinoma	18803288	CNVD
Breast cancer	21364760	CNVD
Metastatic melanoma	18483359	CNVD
Glioblastoma	19074898	CNVD
Malignant melanoma	19074898	CNVD
Prostate cancer	16573809	CNVD
Metanephric adenoma	20802469	CNVD
Medulloblastoma	16783165	CNVD
Dyslexia	22102821	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Medullary thyroid carcinoma	18765511	CNVD
Schizophrenia	21346763	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
early-passage human iPS cells	21368824	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	22522925	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD

Chromatin state (count:92 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:6648200-6670400	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
2	chr9:6648400-6658200	Weak transcription	A549	lung
3	chr9:6648400-6669400	Weak transcription	H9 Cell Line	embryonic stem cell
4	chr9:6648400-6680400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
5	chr9:6648600-6677600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
6	chr9:6648600-6680400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
7	chr9:6648800-6680400	Weak transcription	H1 Cell Line	embryonic stem cell
8	chr9:6649800-6664200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr9:6650000-6658400	Weak transcription	HepG2	liver
10	chr9:6654000-6669400	Weak transcription	HUES48 Cell Line	embryonic stem cell
11	chr9:6656600-6659400	Enhancers	Liver	Liver
12	chr9:6657000-6658600	Enhancers	GM12878-XiMat	blood
13	chr9:6657200-6669400	Weak transcription	HUES6 Cell Line	embryonic stem cell
14	chr9:6657200-6669800	Weak transcription	HUES64 Cell Line	embryonic stem cell
15	chr9:6657200-6680400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
16	chr9:6657400-6664400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
17	chr9:6657400-6680400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
18	chr9:6657400-6680400	Weak transcription	Cortex derived primary cultured neurospheres	brain
19	chr9:6658200-6659000	Enhancers	A549	lung
20	chr9:6658400-6659200	Enhancers	HepG2	liver
21	chr9:6658600-6667600	Weak transcription	GM12878-XiMat	blood
22	chr9:6658800-6659200	Enhancers	HUVEC	blood vessel
23	chr9:6659000-6662200	Weak transcription	A549	lung
24	chr9:6659200-6661400	Weak transcription	HepG2	liver
25	chr9:6659200-6664600	Weak transcription	HUVEC	blood vessel
26	chr9:6659400-6660800	Weak transcription	Liver	Liver
27	chr9:6660800-6664200	Enhancers	Liver	Liver
28	chr9:6661400-6661600	Enhancers	HepG2	liver
29	chr9:6661600-6662000	Weak transcription	HepG2	liver
30	chr9:6662000-6664200	Enhancers	HepG2	liver
31	chr9:6662200-6662600	Enhancers	A549	lung
32	chr9:6662600-6662800	Flanking Active TSS	A549	lung
33	chr9:6662800-6664200	Enhancers	A549	lung
34	chr9:6664200-6664600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr9:6664200-6664800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
36	chr9:6664200-6664800	Flanking Active TSS	Liver	Liver
37	chr9:6664200-6665000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
38	chr9:6664200-6665000	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
39	chr9:6664200-6665000	Enhancers	Stomach Mucosa	stomach
40	chr9:6664200-6665200	Enhancers	Placenta	Placenta
41	chr9:6664200-6665200	Enhancers	Gastric	stomach
42	chr9:6664200-6665400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
43	chr9:6664200-6665400	Enhancers	Pancreas	Pancrea
44	chr9:6664200-6665400	Enhancers	Rectal Mucosa Donor 31	rectum
45	chr9:6664200-6665800	Enhancers	Hela-S3	cervix
46	chr9:6664200-6665800	Flanking Active TSS	HepG2	liver
47	chr9:6664200-6666000	Enhancers	Fetal Intestine Large	intestine
48	chr9:6664200-6666000	Enhancers	Fetal Intestine Small	intestine
49	chr9:6664200-6666000	Flanking Active TSS	A549	lung
50	chr9:6664400-6664800	Enhancers	ES-I3 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links